Vaccine Design and Testing – News and Features
News
Promising Lassa Fever Vaccine Prevents Disease and Death in Preclinical Animal Models
Researchers developed the LASSARAB vaccine, using a deactivated rabies virus to protect against Lassa fever. In preclinical trials, it prevented severe disease and death in animals.
News
Solving the Mystery of Hepatitis C
Around 300,000 people die from hepatitis C every year. A new study is the first to map the protein complex that enables the virus to infect our cells, potentially paving the way for an effective vaccine.
News
Monoclonal Antibody Shows Promise Against Multiple COVID-19 Variants
The monoclonal antibody SC27 effectively neutralizes numerous SARS-CoV-2 variants and related coronaviruses. SC27 targets multiple sites on the spike protein, showing broad protection in lab tests and animal models.
News
Antibody Discovery Offers New Hope in the Search for a Universal COVID-19 Vaccine
Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, which could better protect the population against current and future variants.
News
Researchers Uncover the Factors That Contribute to COVID-19 Vaccine Side Effects
A pilot study identified that stress, BMI, exercise, and hormonal birth control influence COVID-19 vaccine side effects. Notably, exercise impacts side effects differently between doses.
News
Universal Flu Vaccine Candidate Shows Promise in Animal Models
Researchers developed a universal flu vaccine, which analyzed thousands of virus strains to identify conserved proteins. In animal trials, the vaccine elicited a strong immune response and provided protection against multiple flu strains.
News
T Cells Determine the Effectiveness of Vaccine-Induced Immunity Against Flu
Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine found that T follicular helper cells determine the effectiveness of vaccine-induced immunity against flu.
News
Researchers Obtain a Detailed Picture of the SARS-CoV-2 Infection Process
A team has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19. They have found new insights into how the virus infects human cells and how it can be neutralized.
News
What Happens When TB Strains and Hosts Share Roots?
Highly localized TB strains are less infectious in cosmopolitan cities and more likely to infect people from the geographic area that is the strain’s natural habitat.
News
Shared Geographic Origin Between TB Strain and Human Host Amplifies Risk of Infection
Researchers have discovered that highly localized TB strains are less infectious in cosmopolitan cities and more likely to infect people from the geographic area that is the strain’s natural habitat.
Advertisement